ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters…
| Price | $3.14 |
|---|---|
| Market cap | $394.71M |
| Sector | Basic Materials |
| Industry | Chemicals - Specialty |
| Exchange | NASDAQ |
| 52-week range | 3.05-14.49 |
| Beta | 3.6 |
Explore ASPI's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.